http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100483195-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36
filingDate 2002-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100483195-B1
titleOfInvention Pharmaceutical compositions for protection and remidy of Dirofilaria immitis infection comprising arsenic oxide effective components
abstract The present invention provides As 4 O 6 as an active ingredient for the prevention and treatment of filamentous worms, which is an infection of mammals and humans, including dogs, cats, ferrets, foxes, wolves, sea lions and horses. For the prevention and treatment of filamentousworms A pharmaceutical composition comprising As 4 O 6 as an active ingredient in mammals and humans, including dogs, cats, ferrets, foxes, wolves, sea lions and horses infected with Dirophyllaria imitis in more detail. Pharmaceutical for administering the composition to prevent and treat filamentous worms It relates to a composition.n n n In another aspect, the present invention is administered to a mammal, including dogs, cats, ferrets, foxes, wolves, sea lions, horses, and humans infected with parasites to the pharmaceutical composition comprising As 4 O 6 as an active ingredient from the mammals and humans It relates to a pharmaceutical composition for preventing and treating parasites for preventing and treating various parasites generated.
priorityDate 2002-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5550153-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3883650-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5281588-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100272835-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020002033-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6445091
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426147432
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID6287
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID6287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10749
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID6282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415910378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID261004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321424
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID6282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426149772
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9685
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID519065
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID519065
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531966

Total number of triples: 35.